“Off-label use is reasonable.”
2024-09-22View profile →
Weekly 5–7mg cycles.
“Off-label use is reasonable.”
“Promising, but human evidence is thin.”
“Worth tracking; not yet first-line.”
Across 2 ledger entries below — what we're weighing, in order of strength.
Financial interests don't invalidate arguments — but you should know.
Native comments, Twitter mentions, and Reddit threads about this protocol — surfaced together so the conversation isn't fragmented across platforms.
Posting publicly as Ellen · linked to your social profiles
I've been recommending this to patients for 6 months now. The big shift is patients actually do it because the explanation is concrete.
Same in nutrition counseling. The before/after framing helps.
Tracking with a CGM on top of this for 3 months. Variability dropped quickly and stayed dropped.
Whalespan view: Rapamycin (low-dose) is genuinely contested. Smart, careful people read the same papers and reach different conclusions. Don't accept anyone's pitch — including ours — without working through the disagreements yourself.